RUNX1 mediates the therapeutic effects of mesenchymal stem cells-derived microparticles in acute respiratory distress syndrome

Clin Transl Med. 2023 Nov;13(11):e1455. doi: 10.1002/ctm2.1455.
No abstract available

Publication types

  • Letter

MeSH terms

  • Core Binding Factor Alpha 2 Subunit
  • Humans
  • Mesenchymal Stem Cell Transplantation*
  • Mesenchymal Stem Cells*
  • Respiratory Distress Syndrome* / therapy

Substances

  • Core Binding Factor Alpha 2 Subunit
  • RUNX1 protein, human